July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Drew Moghanaki: SAFRON II Was a “SABR in Lieu of Systemic Therapy” Study for Lung Metastases
Jun 7, 2025, 12:39

Drew Moghanaki: SAFRON II Was a “SABR in Lieu of Systemic Therapy” Study for Lung Metastases

Drew Moghanaki, Chief Medical Officer at Respirati and Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology at David Geffen School of Medicine at UCLA, shared a post on X:

“Prof. Shankar Siva reminds us that SAFRON II was a ‘SABR in lieu of systemic therapy’ study for patients with lung metastases at SABRCAN 2025.”

Drew Moghanaki: SAFRON II Was a "SABR in Lieu of Systemic Therapy" Study for Lung Metastases

More posts featuring Drew Moghanaki.